CymaBay Therapeutics, Inc.
Industry: Life Sciences ・ $CBAY on Nasdaq
Insider Sale
+$143,160
-100%
Shares
Shares Volume: 6,000 Shares
Average Share Price: $23.86
INSIDER
Dorling Janet
Director
reported on Jan 10 2024
traded on Jan 10 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 0 |
| PURCHASES/SALES 1Y | 0 / 3 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $123,420 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
| PURCHASES/SALES 1Y | 0 / 28 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $311,656.36 |
| COMPANY PREVIOUS TRADES |